Vedanta Biosciences, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jul 2034
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Jan 16 to 18, 2027 · next Jan 16
- 1 fee due Apr 29, 2027The maintenance fee for Treatment of Clostridium Difficile Infection (US 10,456,431) comes due Apr 29, 2027. Unpaid by Oct 29, 2027, it lapses early.
- 1 fee due May 14, 2027The maintenance fee for Methods and Compositions for Preserving Bacteria (US 11,814,615) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
- 1 fee due Jun 17, 2027The maintenance fee for Compositions and Methods for the Treatment of Allergy (US 10,507,221) comes due Jun 17, 2027. Unpaid by Dec 17, 2027, it lapses early.
- 1 fee due Aug 11, 2027The maintenance fee for Treatment of Clostridium Difficile Infection (US 10,555,980) comes due Aug 11, 2027. Unpaid by Feb 11, 2028, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 20, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,764,019 | Compositions Containing Combinations of Bioactive Molecules Derived from Microbiota for Treatment of Disease In force · High confidence | In force | High confidence | |
| US 9,999,641 | Treatment of Clostridium Difficile Infection In force · Medium confidence | In force | Medium confidence | |
| US 10,064,904 | Treatment of Clostridium Difficile Infection In force · Medium confidence | In force | Medium confidence | |
| US 10,350,250 | Treatment of Clostridium Difficile Infection In force · Medium confidence | In force | Medium confidence | |
| US 10,456,431 | Treatment of Clostridium Difficile Infection In force · Medium confidence | In force | Medium confidence | |
| US 10,555,980 | Treatment of Clostridium Difficile Infection In force · Medium confidence | In force | Medium confidence | |
| US 11,701,396 | Treatment of Clostridium Difficile Infection In force · Medium confidence | In force | Medium confidence | |
| US 12,390,498 | Treatment of Clostridium Difficile Infection In force · Medium confidence | In force | Medium confidence | |
| US 11,447,738 | Methods and Compositions for Preserving Bacteria In force · High confidence | In force | High confidence | |
| US 11,814,615 | Methods and Compositions for Preserving Bacteria In force · High confidence | In force | High confidence |
Also on record, not counted in the 18: 1 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 pending · 6 abandoned